BACKGROUND: Colorectal cancer (CRC) screening is underutilized despite evidence that screening reduces mortality. OBJECTIVE: To assess the effect of an intervention targeting physicians and their patients on rates of CRC screening. DESIGN: A randomized clinical trial of community physicians and their patients. PARTICIPANTS: Ninety-four community primary care physicians randomly assigned to an intervention consisting of academic detailing and direct mailings to patients or a control group. Patients aged 50 to 79 years in the intervention group physicians received aletter from their physician, a brochure on CRC screening, and a packet of fecal occult blood test (FOBT) cards. MEASUREMENTS: After 1 year we measured receipt of the following: (1) FOBT in the past 2 years, (2) flexible sigmoidoscopy (SIG) or colonoscopy (COL) in the previous 5 years, and (3) any CRC screening. We report the percent change from baseline in both groups. RESULTS:9,652 patients were enrolled for 2 years, and 3,732 patients were enrolled for 5 years. There was no increase in any CRC screening that occurred in the intervention group for patients enrolled for 2 years (12.7 increase vs 12.5%, P=.51). Similar results were seen for any CRC screening among patients enrolled for 5 years (9.7% increase vs 8.6%, P=.45). The only outcome on which the intervention had an effect was on patient rates of screening SIG (7.4% increase vs 4.4%, P<.01). CONCLUSION: With the exception of an increase in rates of SIG in the intervention group, the intervention had no effect on rates of CRC screening. Future interventions should assess innovative approaches to increase rates of CRC screening.
RCT Entities:
BACKGROUND:Colorectal cancer (CRC) screening is underutilized despite evidence that screening reduces mortality. OBJECTIVE: To assess the effect of an intervention targeting physicians and their patients on rates of CRC screening. DESIGN: A randomized clinical trial of community physicians and their patients. PARTICIPANTS: Ninety-four community primary care physicians randomly assigned to an intervention consisting of academic detailing and direct mailings to patients or a control group. Patients aged 50 to 79 years in the intervention group physicians received a letter from their physician, a brochure on CRC screening, and a packet of fecal occult blood test (FOBT) cards. MEASUREMENTS: After 1 year we measured receipt of the following: (1) FOBT in the past 2 years, (2) flexible sigmoidoscopy (SIG) or colonoscopy (COL) in the previous 5 years, and (3) any CRC screening. We report the percent change from baseline in both groups. RESULTS: 9,652 patients were enrolled for 2 years, and 3,732 patients were enrolled for 5 years. There was no increase in any CRC screening that occurred in the intervention group for patients enrolled for 2 years (12.7 increase vs 12.5%, P=.51). Similar results were seen for any CRC screening among patients enrolled for 5 years (9.7% increase vs 8.6%, P=.45). The only outcome on which the intervention had an effect was on patient rates of screening SIG (7.4% increase vs 4.4%, P<.01). CONCLUSION: With the exception of an increase in rates of SIG in the intervention group, the intervention had no effect on rates of CRC screening. Future interventions should assess innovative approaches to increase rates of CRC screening.
Authors: A B Coffield; M V Maciosek; J M McGinnis; J R Harris; M B Caldwell; S M Teutsch; D Atkins; J H Richland; A Haddix Journal: Am J Prev Med Date: 2001-07 Impact factor: 5.043
Authors: Martin P Charns; Mary K Foster; Elaine C Alligood; Justin K Benzer; James F Burgess; Donna Li; Nathalie M McIntosh; Allison Burness; Melissa R Partin; Steven B Clauser Journal: J Natl Cancer Inst Monogr Date: 2012-05
Authors: Jill Tinmouth; Paul Ritvo; S Elizabeth McGregor; Jigisha Patel; Crissa Guglietti; Cheryl A Levitt; Lawrence F Paszat; Linda Rabeneck Journal: Can Fam Physician Date: 2013-12 Impact factor: 3.275
Authors: Margaret Jin; Terryn Naumann; Loren Regier; Shawn Bugden; Michael Allen; Lena Salach; Kristen Chelak; Nancy Blythe; Antony Gagnon; Lisa Dolovich Journal: Can Pharm J (Ott) Date: 2012-05
Authors: Judith M E Walsh; Rene Salazar; Tung T Nguyen; Celia Kaplan; Lam Kieu Nguyen; Jimmy Hwang; Stephen J McPhee; Rena J Pasick Journal: Am J Prev Med Date: 2010-07 Impact factor: 5.043
Authors: Amy McQueen; L Kay Bartholomew; Anthony J Greisinger; Gilda G Medina; Sarah T Hawley; Paul Haidet; Judith L Bettencourt; Navkiran K Shokar; Bruce S Ling; Sally W Vernon Journal: J Gen Intern Med Date: 2009-09-18 Impact factor: 5.128